FiercePharma Manufacturing The FDA has kept a close eye on Chinese heparin makers ever since tainted crude heparin from China was tied to the deaths of dozens of dialysis patients in the U.S. The agency has now taken steps against a Chinese heparin maker it says is using ...
The Pharma Letter It is projected that the heparin active pharmaceutical ingredient (API) in China will achieve an additional capacity of more than 20 trillion units b...
Science Codex Heparin , the life saving blood thinner used in major surgeries and treatment of heart diseases, is a complicated drug but a research team from the Univer...
Anesthesiology News “Currently, there is insufficient data regarding the risk of neuraxial hematoma for analgesia in conjunction with heparin administered three times daily,” noted Jackson Su, MD, assistant professor of anesthesiology and perioperative medicine at the ...
Regulatory Focus A Chinese-based manufacturer of heparin products has been sent a Warning Letter by the US Food and Drug Administration (FDA) after regulators accused the company of preventing FDA inspectors from accessing the facility earlier this year, and possibly ...
In-PharmaTechnologist.com The resulting crude heparin will be processed into API at Pharma Action's refinement plant in Berlin, which has capacity to produce 10 tonnes...
FiercePharma Manufacturing After tainted Chinese heparin in 2008 led to dozens of deaths of dialysis patients in the U.S., global regulators started preaching loud and clear on the need for heparin makers to be able to track back sources to ensure they were safe. German meat ...
MedPage Today Across five countries, hospital costs per patient were a median of $39,508 with dalteparin (Fragmin) compared with $40,805 on unfractionated heparin , Rob...
The Biological SCENE A research team led by Jayachandran N. Kizhakkedathu of the University of British Columbia recently designed a reversal agent for heparin (Sci. Tr...
In-PharmaTechnologist.com Heparin production may be moving back to Europe according to the EFCG, which cited the opening of Pharma Action's processing plant as an indication that API buyers value quality and compliance throughout the supply chain. and more »
